261 related articles for article (PubMed ID: 12659767)
1. Substituted benzo[i]phenanthridines as mammalian topoisomerase-targeting agents.
Makhey D; Li D; Zhao B; Sim SP; Li TK; Liu A; Liu LF; LaVoie EJ
Bioorg Med Chem; 2003 Apr; 11(8):1809-20. PubMed ID: 12659767
[TBL] [Abstract][Full Text] [Related]
2. 2,3-Dimethoxybenzo[i]phenanthridines: topoisomerase I-targeting anticancer agents.
Li D; Zhao B; Sim SP; Li TK; Liu A; Liu LF; LaVoie EJ
Bioorg Med Chem; 2003 Feb; 11(4):521-8. PubMed ID: 12538017
[TBL] [Abstract][Full Text] [Related]
3. Substituted dibenzo[c,h]cinnolines: topoisomerase I-targeting anticancer agents.
Yu Y; Singh SK; Liu A; Li TK; Liu LF; LaVoie EJ
Bioorg Med Chem; 2003 Apr; 11(7):1475-91. PubMed ID: 12628673
[TBL] [Abstract][Full Text] [Related]
4. 11-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives as novel topoisomerase I-targeting agents.
Feng W; Satyanarayana M; Tsai YC; Liu AA; Liu LF; LaVoie EJ
Bioorg Med Chem; 2008 Sep; 16(18):8598-606. PubMed ID: 18771930
[TBL] [Abstract][Full Text] [Related]
5. Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity.
Ruchelman AL; Zhu S; Zhou N; Liu A; Liu LF; LaVoie EJ
Bioorg Med Chem Lett; 2004 Nov; 14(22):5585-9. PubMed ID: 15482929
[TBL] [Abstract][Full Text] [Related]
6. 8,9-methylenedioxybenzo[i]phenanthridines: topoisomerase I-targeting activity and cytotoxicity.
Li D; Zhao B; Sim SP; Li TK; Liu A; Liu LF; LaVoie EJ
Bioorg Med Chem; 2003 Aug; 11(17):3795-805. PubMed ID: 12901925
[TBL] [Abstract][Full Text] [Related]
7. Esters and amides of 2,3-dimethoxy-8,9-methylenedioxy-benzo[i]phenanthridine-12-carboxylic acid: potent cytotoxic and topoisomerase I-targeting agents.
Zhu S; Ruchelman AL; Zhou N; Liu AA; Liu LF; LaVoie EJ
Bioorg Med Chem; 2005 Dec; 13(24):6782-94. PubMed ID: 16153852
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative activity of O4-benzo[c]phenanthridine alkaloids against HCT-116 and HL-60 tumor cells.
Hatae N; Fujita E; Shigenobu S; Shimoyama S; Ishihara Y; Kurata Y; Choshi T; Nishiyama T; Okada C; Hibino S
Bioorg Med Chem Lett; 2015 Jul; 25(14):2749-52. PubMed ID: 26026362
[TBL] [Abstract][Full Text] [Related]
9. 12-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridines as novel topoisomerase I-targeting antitumor agents.
Feng W; Satyanarayana M; Tsai YC; Liu AA; Liu LF; LaVoie EJ
Bioorg Med Chem; 2009 Apr; 17(7):2877-85. PubMed ID: 19303306
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives.
Janin YL; Croisy A; Riou JF; Bisagni E
J Med Chem; 1993 Nov; 36(23):3686-92. PubMed ID: 8246238
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological activity and comparative analysis of DNA binding affinities and human DNA topoisomerase I inhibitory activities of novel 12-alkoxy-benzo[c]phenanthridinium salts.
Lynch MA; Duval O; Sukhanova A; Devy J; MacKay SP; Waigh RD; Nabiev I
Bioorg Med Chem Lett; 2001 Oct; 11(19):2643-6. PubMed ID: 11551768
[TBL] [Abstract][Full Text] [Related]
12. Identification of topoisomerase I as the cytotoxic target of the protoberberine alkaloid coralyne.
Gatto B; Sanders MM; Yu C; Wu HY; Makhey D; LaVoie EJ; Liu LF
Cancer Res; 1996 Jun; 56(12):2795-800. PubMed ID: 8665516
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of topoisomerase I function by nitidine and fagaronine.
Wang LK; Johnson RK; Hecht SM
Chem Res Toxicol; 1993; 6(6):813-8. PubMed ID: 8117920
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxic activities of a new benzo[c]phenanthridine alkaloid, 7-hydroxynitidine, and some 9-oxygenated benzo[c]phenanthridine derivatives.
Nakanishi T; Suzuki M
Org Lett; 1999 Oct; 1(7):985-8. PubMed ID: 10825951
[TBL] [Abstract][Full Text] [Related]
15. Coralyne and related compounds as mammalian topoisomerase I and topoisomerase II poisons.
Makhey D; Gatto B; Yu C; Liu A; Liu LF; LaVoie EJ
Bioorg Med Chem; 1996 Jun; 4(6):781-91. PubMed ID: 8818227
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumour activities of a new benzo[c]phenanthridine agent, 2,3-(methylenedioxy)-5-methyl-7-hydroxy-8-methoxybenzo[c]phena nthridini um hydrogensulphate dihydrate (NK109), against several drug-resistant human tumour cell lines.
Kanzawa F; Nishio K; Ishida T; Fukuda M; Kurokawa H; Fukumoto H; Nomoto Y; Fukuoka K; Bojanowski K; Saijo N
Br J Cancer; 1997; 76(5):571-81. PubMed ID: 9303354
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxic activity of benzo[c][1,7] and [1,8]phenanthrolines analogues of nitidine and fagaronine.
Prado S; Michel S; Tillequin F; Koch M; Pfeiffer B; Pierré A; Léonce S; Colson P; Baldeyrou B; Lansiaux A; Bailly C
Bioorg Med Chem; 2004 Jul; 12(14):3943-53. PubMed ID: 15210161
[TBL] [Abstract][Full Text] [Related]
18. Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.
Holden JA; Wall ME; Wani MC; Manikumar G
Arch Biochem Biophys; 1999 Oct; 370(1):66-76. PubMed ID: 10496978
[TBL] [Abstract][Full Text] [Related]
19. Molecular determinants of site-specific inhibition of human DNA topoisomerase I by fagaronine and ethoxidine. Relation to DNA binding.
Fleury F; Sukhanova A; Ianoul A; Devy J; Kudelina I; Duval O; Alix AJ; Jardillier JC; Nabiev I
J Biol Chem; 2000 Feb; 275(5):3501-9. PubMed ID: 10652345
[TBL] [Abstract][Full Text] [Related]
20. QSAR modeling on benzo[c]phenanthridine analogues as topoisomerase I inhibitors and anti-cancer agents.
Thai KM; Bui QH; Tran TD; Huynh TN
Molecules; 2012 May; 17(5):5690-712. PubMed ID: 22580401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
